Plenary Speakers

Oral Session - 2

Abstract	Presenter	Abstract Title
200	Eftychia Eirini Maria Gourdoupari	Prognostic cut-off values of neutrofil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for COVID-19: a case-control retrospective single-center study
584	Şiran Keske	Insights from One of the Largest COVID-19 Cohorts: A Detailed Analysis of Risk Factors, Mortality Predictors, and Vaccine Efficacy in Istanbul
145	Arzuhan Buyuker	Evaluation of The Anti-Viral Response Against SARS-CoV-2 Omicron Variant Appeared In The First Half of 2024 in Healthcare Workers Using In Vitro Cell Culture Model
539	Eda Alp	Association of Hepatitis-B virus infection status with survival and treatment response in non-small cell lung cancer patients on anti-pd-1/pd-l1 therapy
668	Nida Özcan	Changes in Hepatitis C Virus Genotype Distribution in Diyarbakır from 2011 to 2020: The Impact of Migration and Epidemiological Trends
348	Abdul Mannan Mustafa	HIV through the mind of people unknowingly living among HIV patients; KAP study about HIV in slum area of Pakistan
500	Jonathan Nkalubo	Factors associated with readiness to start antiretroviral therapy (ART) among young people (15-24 years) at four HIV clinics in Mulago Hospital, Uganda
625	Elif Türkmen	Effectıveness Of Fecal Mıcrobıota Transplantatıon In Chıldren Wıth Inflammatory Bowel Dısease
677	Alfonso J. Rodriguez-Morales	Relationships between morbidity from Mpox and international tourism globally during 2022-2024 epidemics

Oral Session - 3

Abstract	Presenter	Abstract Title
581	Evangelos J. Giamarellos Bourboulis	Clarithromycin adjunct treatment leads to substantial financial savings in community-acquired pneumonia: sub-analysis of the ACCESS trial
367	Luca Mezzadri	Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections
530	Sohayeb Mohamed Ayoub	The Role of Students in Improving Patient Safety: An Integrative Approach
649	Nofri Rahmadika	Altered Interferon Responses in Tuberculosis Patients with Type II Diabetes: Implications for Increased Disease Susceptibility
372	Matthijs S Berends	Impact of Pre-Existing Comorbidities and Multimorbidities, Demography and Viral Variants on Post-Acute Sequelae of COVID-19 (‘Long COVID’) in Dutch Primary Care: A Retrospective Cohort Study
470	Meltem Ayaş	The investigation of the effectiveness of TK medium in determining primary anti-tuberculosis drug susceptibilities of Mycobacterium tuberculosis and a newly developed pyrazinamide susceptibility test
303	Emine Alp	The Effect of Training and Monitoring of Environmental Cleaning on The Rates of Intensive Care Unit Acquired Infections in A University Hospital
623	Reham Khedr	Successful management of pediatric patients with low-risk febrile neutropenia using a clinical care pathway in Egypt
195	Shinya Tsuzuki	Antimicrobial use for influenza-like illnesses in Nha Trang, Vietnam

Oral Session - 1

Abstract	Presenter	Abstract Title
182	Reshma Silvester	A peek into hospital poo: Tracking pathogens and antimicrobial resistance
298	Shakeel Mowlaboccus	Genomic characterisation of vancomycin variable Enterococcus faecium causing bacteraemia in Australia
364	Huynh Ngoc Tram Vo	Genomic features of carbapenem-resistant Klebsiella pneumoniae isolated in French Polynesia and description of a novel transposon Tn7722 responsible for NDM-1 dissemination
660	Huda Ahmed	Distribution of Minimum Inhibitory Concentrations and Resistance-associated Gene Mutations in Multidrug-resistant Mycobacterium tuberculosis Strains from Southern Türkiye: Insights on Bedaquiline, Delamanid, and Linezolid
79	Igor Mokrousov	Genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levels
652	Şevval Arduç Tok	Ceftazidim-avibactam susceptibility of carbapenemase producing enterobacterales in an oxa-48 endemic area
386	Neşe İnal	In-Vitro Antimicrobial Susceptibility Results of Brucella Species in Eastern Türkiye
692	Maryam Taghizadeh-Ghehi	Pattern of antibiotic use over two decades in Iran: a national level assessment based on WHO AWaRe classification from 2000 to 2019
191	Tuba Sena Karacesme	Potential Drug Interactions With Antibiotics On Intensive Care Units: A Retrospective Cross-Sectional Study

ISAC / ICC Early Career Scientist Workshop

Organised by the ISAC Early Career Working Group

Join us at the ICC 2024 Early Career Scientist Workshop, an exciting and integral part of our conference, designed specifically to highlight and foster the growth of new talent in the field of antimicrobial chemotherapy. This year, we are thrilled to feature presentations from the ISAC/ICC awardees, representing a diverse range of countries and research backgrounds. These early career scientists have been recognised for their exceptional contributions and will share their innovative research findings with the global community. The workshop not only offers a unique opportunity for these emerging researchers to gain visibility but also provides a platform for all attendees to engage with cutting-edge science, discuss novel ideas, and build collaborative networks.

Getting Your Paper Published: What You Need to Know as an Author

Organised in collaboration with Elsevier

In this session hosted by Elsevier and the ISAC journal Editors (Journal of Global Antimicrobial Resistance and International Journal of Antimicrobial Agents) you will learn about the journals’ publishing system from the author’s perspective. This will include a detailed breakdown of the steps from submission to publication as well as how best to respond to peer reviewer comments. Publishing a paper can often be a daunting experience, especially for junior researchers, and we hope this session equips you with the skills, the tips and tricks, and the confidence you need to disseminate your research in a journal.

Improving Antimicrobial Use in Intensive Care Units

Optimal antimicrobial therapy is essential for critically ill patients in the intensive care unit (ICU). This workshop will focus on important issues and strategies to enhance the effectiveness of antimicrobial therapy in critically ill patients. The topics that will be covered include the use of broad-spectrum antimicrobials and antimicrobial de-escalation in the ICU, as well as the value of clinical microbiology to guide decision making in the management of critically ill patients. This session is targeted at healthcare professionals working in intensive care, including clinicians, pharmacists, nurses, as well as researchers interested in improving patient outcomes through better antimicrobial stewardship and strategies.

Sustainability and IPC

Organised by the ISAC Infection Prevention & Control Working Group

In general, sustainability and environmental protection are global topics of upmost importance. After the recent COVID-19 pandemic, sustainability in regard to infection prevention and control measures within the healthcare setting finally got the needed attention. Unfortunately, efforts to protect our environment and those to protect our patients seem to clash at times, in part, due to the lack of data or knowledge. This session aims to elude this conflict and give an overview of what is presently known to achieve the best for both goals.

"From bench to bedside" Optimising antibiotic use with Pharmacokinetics/Pharmacodynamics (PKPD)

Description of the interactive session

The aim of this interactive session is to cover the basic aspects of antibiotic pharmacokinetics (PK) and pharmacodynamics (PD). Participants will be expected to play an active role in discussions.

Learning Outcomes:

To provide a basic understanding for the pharmacokinetic (PK) and pharmacodynamic (PD) properties of anti-infective drugs.

To introduce in vitro and in vivo modeling as a tool to interpret PK and PD of antimicrobials.

To highlight the importance of using PK/PD to optimize the antimicrobial treatment.

To facilitate the use of therapeutic drug monitoring to optimize antibiotic treatment in patients.

Target Audience

Infectious diseases physicians, pharmacists, intensivists, microbiologists, advanced nurse practitioners in the ICU, and researchers.

"From bench to bedside" Antimicrobial Susceptibility Testing Guided by EUCAST

Don’t miss this unique opportunity to dive deep into the latest advancements in antimicrobial susceptibility testing guided by EUCAST (European Committee on Antimicrobial Susceptibility Testing) standards.

Why Attend?
✅ Learn cutting-edge techniques to ensure precise antimicrobial therapy
✅ Bridge the gap between laboratory results and clinical decision-making
✅ Master EUCAST guidelines to enhance patient outcomes
✅ Hands-on sessions with expert microbiologists and clinicians

This interactive session is designed for infectious disease specialists, microbiologists, pharmacologists and healthcare professionals eager to stay ahead in the fight against antimicrobial resistance.

Building an Antimicrobial Stewardship Programme: Challenges and Achievements

Unlock the power to combat antimicrobial resistance with our cutting-edge Interactive Session, “Building an Antimicrobial Stewardship Programme”!

This isn’t just an interactive session—it’s your opportunity to lead the charge in transforming how antibiotics are used in your healthcare setting. Guided by top experts, you’ll gain actionable insights into developing a successful stewardship programme from the ground up. Learn to design strategies that reduce resistance, improve patient outcomes and ensure the responsible use of antimicrobials, all while staying ahead of global healthcare trends.

Elevate your expertise, make a real-world impact and be at the forefront of innovation in antimicrobial stewardship. This is your chance to be a changemaker—don’t miss out!

One Health Workshop

You are invited to a unique, very easy and transformative learning experience, one that will reshape how you view and address the pressing challenges of today. This smart, interactive session will introduce you to One Health, an innovative interdisciplinary approach that tackles some of the world’s most critical issues.

We will focus specifically on One Health and two major topics: zoonotic diseases and climate change. Traditionally, health improvement efforts have been centered around interventions for humans alone. However, as scientific research has advanced, it has become clear that we can only make lasting progress by addressing the interconnected health of humans, animals, and the environment. This holistic approach is essential if we are to combat challenges such as antimicrobial resistance, climate change, the rise of zoonotic diseases, food safety, and other global health crises.

Have you thought about the true drivers of climate change? Or the vital role the environment plays in the transmission of zoonotic diseases? These crucial issues will be explored in an engaging and dynamic way during “The One Health Workshop”.

To participate fully in this very easy learning experience, please ensure you have your “Gmail account” ready, along with a “QR & barcode scanner app” installed on your smartphone. This journey will not only deepen your understanding of One Health and its key elements but also serve as the foundation for a new chapter in your professional growth. Don’t miss this incredible opportunity—it’s time to embrace a smarter, more comprehensive approach to getting information.

Rapid Diagnostics & Targeted Antimicrobial Therapy in Sepsis Management.

Date: November 5th, 2024 / Time: 12:00 – 13:30 / Location: Hall 1

Chair: Prof. Murat Akova

TOPICS	EXPERTS
Welcoming and Introduction	Prof. Murat Akova Chairman
Nosocomial Pneumonia & Early Antimicrobial Therapy	Prof. Önder Ergönül
Sepsis: Strategies for Rapid Diagnosis & Management	Prof. İlker Devrim
Panel Discussion (Q&A)

Tackling AMR in CA-RTIs: optimising outcomes with evidence-based decision making

Date: November 4th, 2024 / Time: 11:45 – 13:15 / Location: Hall 1

Chair: Prof. Serhat Ünal

Time	Session title	Presenter
11:45–11:55	Welcome and introduction	Serhat Ünal (Turkey)
11:55–12:10	Keeping an eye on AMR: applying surveillance data to clinical practice	Rafael Cantón (Spain)
12:10–12:20	Panel discussion	All
12:20–12:35	Using real-world data to drive treatment success	Vu Do (Vietnam)
12:35–12:45	Panel discussion	All
12:45–13:00	Optimising dosing to improve patient outcomes and manage AMR	Balaji Veeraraghavan (India)
13:00–13:05	Panel discussion	All
13:05–13:15	Concluding remarks	Serhat Ünal (Turkey)

Meet The Experts- Updates on prevention and management of the Respiratory Infections

Date: November 4th, 2024 / Time: 11:45 – 13:15 / Location: Hall 2

11:45-11:50
Opening (All)

11:50- 12:25
Advances in Management of Bacterial CAP- Prof Dr Evangelos Giamarellos-Bourboulis

12:25- 13:00
Influenza Vaccination: Protecting the Public and the Vulnerable- Prof Dr Mine Durusu Över

13:00- 13:15 Discussion and Q&A (All)

Influenza vaccines: Why do we need protection beyond flu?

Date: November 5th, 2024 / Time: 12:00 – 13:30 / Location: Hall 2

Co-Chaired by Meral Akcay-Alireza Mafi

Time	Speakers
12:00-12:05	Co-Chairs	Opening Remarks
12:05- 12:30	Dr. Meral Akcay	Influenza beyond flu!
12:30-13:00	Dr. Alireza Mafi	Protection beyond flu!
13:00-13:30	Discussion and Q&A Session	All

Gunnar Kahlmeter

Souha Kanj

Fred C. Tenover

Ozlem Tureci

Timothy Walsh